Heartworm

BENTOPRILM™ 5/10mg is a dual-action cardiac health tablet designed to support optimal heart function and manage congestive heart failure (CHF) in dogs caused by atrioventricular valve insufficiency (AVVI) or dilated cardiomyopathy (DCM). This formulation combines Pimobendan (5mg), an inodilator that enhances heart muscle contractility and promotes vasodilation, with Benazepril HCl (10mg), an ACE inhibitor that manages blood pressure and reduces fluid retention. The 5/10mg strength is ideal for medium to large dogs, ensuring precise and effective dosing under veterinary guidance. Curated by Vɪsʜɴᴜ Dᴜᴛᴛ Tʀɪᴘᴀᴛʜɪ | Pᴇᴛ Exᴘᴇʀᴛ | Available at PᴇᴛsLɪғᴇsᴛʏʟᴇ Composition Each film-coated tablet contains: Pimobendan BP – 5 mg Benazepril HCl USP – 10 mg Excipients – q.s. Approved colour used Indications Management of congestive heart failure (CHF) in dogs due to: Atrioventricular valve insufficiency (AVVI) Dilated cardiomyopathy (DCM) Supports long-term cardiac function and heart health Benefits Dual mechanism of action: Pimobendan improves heart muscle contraction and vasodilation Benazepril lowers blood pressure and reduces fluid retention Optimized cardiac output for improved energy and vitality Supports management of chronic heart conditions Easy oral administration with accurate dosing Clinically proven inodilator + ACE inhibitor combination Dosage & Administration Administer orally every 12 hours, 1 hour prior to food Dosage based on body weight: Body Weight (kg) 5/10 mg Tablets 20–40 Morning 1 / Evening 1 >40 Morning 2 / Evening 2 Always follow veterinarian guidance for dosage adjustments Other Details Presentation: 3 × 10 film-coated tablets per pack For Use In: Dogs only Category: Veterinary Cardiac Medication | CHF Management Manufacturer: PaWPhilia, A Division of Zemex Storage: Store in a cool, dry place, away from sunlight

Read more less

BENTOPRILM™ 2.5/5mg is a dual-action cardiac health tablet for dogs, designed to support optimal heart function and manage congestive heart failure (CHF) caused by atrioventricular valve insufficiency (AVVI) or dilated cardiomyopathy (DCM). The combination of Pimobendan (2.5mg) and Benazepril HCl (5mg) delivers enhanced heart muscle contractility, vasodilation, and reduced blood pressure, helping dogs maintain energy, vitality, and long-term cardiac health. The 2.5/5mg strength is ideal for small to medium-sized dogs, allowing precise dosing under veterinary guidance. Curated by Vɪsʜɴᴜ Dᴜᴛᴛ Tʀɪᴘᴀᴛʜɪ | Pᴇᴛ Exᴘᴇʀᴛ | Available at PᴇᴛsLɪғᴇsᴛʏʟᴇ Composition Each film-coated tablet contains: Pimobendan BP – 2.5 mg Benazepril HCl USP – 5 mg Excipients – q.s. Approved colour used Indications Management of congestive heart failure (CHF) in dogs due to: Atrioventricular valve insufficiency (AVVI) Dilated cardiomyopathy (DCM) Supports long-term cardiac function and heart health Benefits Dual mechanism of action: Pimobendan enhances heart muscle contraction and vasodilation Benazepril reduces blood pressure and fluid retention Optimized cardiac output for improved energy and vitality Supports management of chronic heart conditions Easy oral administration with accurate dosing Clinically proven inodilator + ACE inhibitor combination Dosage & Administration Administer orally every 12 hours, 1 hour prior to food Dosage based on body weight: Body Weight (kg) 2.5/5 mg Tablets 10–20 Morning 1 / Evening 1 20–40 Morning 2 / Evening 2 >40 Consult veterinarian Always follow veterinarian guidance for dosage adjustments Other Details Presentation: 3 × 10 film-coated tablets per pack For Use In: Dogs only Category: Veterinary Cardiac Medication | CHF Management Manufacturer: PaWPhilia, A Division of Zemex Storage: Store in a cool, dry place, away from sunlight

Read more less